Transchem Ltd

Transchem Limited, a micro-cap pharmaceutical company with a market capitalisation of ₹204.00 crores, reported net profit of ₹0.68 crores for Q2 FY26, down 31.31% quarter-on-quarter from ₹0.99 crores in Q1 FY26. The company continues to face operational challenges, with zero sales recorded for the second consecutive quarter whilst remaining almost entirely dependent on other income to sustain profitability.

Transchem Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 1 February 2026. This adjustment reflects a complex interplay of deteriorating financial fundamentals, cautious valuation metrics, and nuanced technical signals, despite the company’s impressive long-term stock returns. Investors are urged to carefully consider these factors amid the evolving market landscape.

Transchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with the latest insights into the company's performance and outlook.

Transchem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Transchem Ltd has surged to a fresh 52-week and all-time high of Rs.194.25, reflecting a robust rally that has propelled the stock to new heights within the Pharmaceuticals & Biotechnology sector. This milestone underscores the stock’s strong momentum amid a broader market environment showing signs of recovery.

Transchem Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.194.25 on 5 Jan 2026, reflecting a sustained period of robust gains and outperforming broader market indices significantly.

Transchem Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week and all-time high of Rs.190.45 today, reflecting a robust rally and sustained momentum over recent trading sessions.

Transchem Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting an all-time high of Rs.190.45 on 2 Jan 2026. This achievement reflects the company’s sustained upward momentum, outperforming both its sector and the broader market over multiple time horizons.

Transchem Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week and all-time high of Rs.186.75 today, reflecting a robust rally and sustained momentum over the past week.

Transchem Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.186.75 today, underscoring a sustained period of robust performance and investor confidence. This milestone reflects the company’s impressive gains over multiple time horizons, significantly outpacing benchmark indices and sector averages.

Transchem Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week and all-time high of Rs.183.11 today, underscoring a remarkable rally that has propelled the stock to fresh heights amid a positive market backdrop.

Transchem Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.183.11 today, underscoring a sustained period of robust performance and significant shareholder value creation.

Transchem Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week and all-time high of Rs.179.52 today, reflecting a robust rally and sustained momentum over recent sessions. This milestone underscores the stock’s remarkable performance amid a mixed market backdrop.

Transchem Ltd, a key player in the Pharmaceuticals & Biotechnology sector, achieved a significant milestone on 30 Dec 2025 by hitting an all-time high of Rs.179.52. This landmark price reflects the company’s sustained strong performance and robust market momentum over recent periods.

Transchem Ltd, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week and all-time high of Rs.178.6 today, reflecting a strong upward momentum that has propelled the stock to this significant milestone.